Publications Library

Astragaloside IV protects against the pathological cardiac hypertrophy in mice

Reversal of pathological cardiac hypertrophy via the MEF2-coregulator interface

Beta-adrenergic regulation of the heart expressing the Ser1700A/Thr1704A mutated Cav1.2 channel

MicroRNA-31 promotes adverse cardiac remodeling and dysfunction in ischemic heart disease

Cyp2c44 gene disruption is associated with increased hematopoietic stem cells : implication in chronic hypoxia-induced pulmonary hypertension

Overexpression of microRNA-26b attenuates angiotensin II-induced cardiac hypertrophy through inhibition of autophagic responses

A CD103+ Conventional Dendritic Cell Surveillance System Prevents Development of Overt Heart Failure during Subclinical Viral Myocarditis

Self-assembling peptide hydrogel enables instant epicardial coating of the heart with mesenchymal stromal cells for the treatment of heart failure

Oestrogen inhibition reverses pulmonary arterial hypertension and associated metabolic defects

AKT2 deficiency induces retardation of myocyte development through EndoG-MEF2A signaling in mouse heart